Clinical Trial Update: Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sitagliptin for dysglycemia in adolescents with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED